ArticleScientific reports2017

Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration.

Wataru Kikushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.